The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients

PACE - Pacing and Clinical Electrophysiology

Volumn 27, Issue 5, 2004, Pages 639-643

  Wiesel, Joseph ^a,b   Wiesel, David ^a   Suri, Ranjit ^a   Messineo, Frank C ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK HOSPITAL QUEENS   (United States)

Author keywords

Atrial fibrillation; Pulse; Sphygmomanometer

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART BEAT; HEART RATE; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PULSE RATE; SPHYGMOMANOMETER;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; AMBULATORY CARE; ATRIAL FIBRILLATION; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; PULSE; SENSITIVITY AND SPECIFICITY; SPHYGMOMANOMETERS;

EID: 2442478154     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2004.00499.x     Document Type: Article

References (15)

1. Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989; 1:175-179.
2. Stroke Prevention in Atrial Fibrillation Investigators. The Stroke Prevention in Atrial Fibrillation Study: Final results. Circulation 1991; 84:527-359.
3. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl Med 1990; 323:1505-1511.
4. Connolly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991; 18:349-355.
5. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl Med 1992; 327:1406-1412.
6. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 1993; 342:1255-1262.
7. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343:687-691.
8. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348:633-638.
9. Lin HJ, Wolf PA, Benjamin EJ, et al. Newly diagnosed atrial fibrillation and acute stroke. The Framingham Study. Stroke 1995; 26:1527-1530.
10. Bell C, Kapral M. Use of ambulatory electrocardiography for the detection of paroxysmal atrial fibrillation in patients with stroke. Canadian Task Force on Preventive Health Care. Can J Neurol Sci 2000; 27:25-31.
11. Check Your Pulse America, Help Prevent Stroke. Brochure. National Stroke Association.
12. Bootsma BK, Hoelsen AJ, Strackee J, et al. Analysis of R-R intervals in patients with atrial fibrillation at rest and during exercise. Circulation 1970; 41:783-794.
13. Catherwood E, Fitzpatrick WD, Greenberg ML, et al. Cost-effectiveness of cardioversion and antiarrhythmic therapy in non-valvular atrial fibrillation. Ann Intern Med 1999; 130:625-636.
14. The AFFIRM Investigators. Survival in patients presenting with atrial fibrillation in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. N Engl J Med 2002; 347:1825-1833.
15. Albers GW, Dalen JE, Laupacis A, et al. Antithrombotic therapy in atrial fibrillation. Chest 2001; 119(Suppl.):194S-206S.